Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy (Q36710571)

15 August 2017

1 reference

title

Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy (English)

1 reference

15 August 2017

Gram-negative bacteria

0 references

antibiotic

0 references

author name string

Abdallah Mahamoud

1

1 reference

15 August 2017

Jacqueline Chevalier

2

1 reference

15 August 2017

Sandrine Alibert-Franco

3

1 reference

15 August 2017

Winfried V Kern

4

1 reference

15 August 2017

Jean-Marie Pagès

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

17 January 2007

1 reference

Journal of Antimicrobial Chemotherapy

15 August 2017

1 reference

15 August 2017

59

1 reference

15 August 2017

6

1 reference

15 August 2017

1223-1229

1 reference

Active efflux, a common mechanism for biocide and antibiotic resistance

15 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

21 January 2018

Vacuuming the periplasm

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Efflux-mediated antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

TolC--the bacterial exit duct for proteins and drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Molecular basis of bacterial outer membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Multidrug efflux pumps and resistance: regulation and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Tracing pathways of transport protein evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Three's company: component structures bring a closer view of tripartite drug efflux pumps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Regulation of bacterial drug export systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

21 January 2018

Antibiotic efflux pumps

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Mechanisms of solvent tolerance in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Efflux pumps: their role in antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Inhibitors of efflux pumps in Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Crystal structures of a multidrug transporter reveal a functionally rotating mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Structural biology: the ins and outs of drug transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Active efflux of bile salts by Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Peptidomimetics of efflux pump inhibitors potentiate the activity of levofloxacin in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

New pyridoquinoline derivatives as potential inhibitors of the fluoroquinolone efflux pump in resistant Enterobacter aerogenes strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL493

21 January 2018

Identifiers

DOI

10.1093/JAC/DKL493

1 reference

15 August 2017

1 reference